David Jack (pharmacologist)
Sir David Jack | |
---|---|
Born | |
Died | 8 November 2011 | (aged 87)
Citizenship | British |
Alma mater |
|
Known for | Drug discovery and development |
Spouse | Lydia Downie Brown (1952–2016) |
Awards |
|
Scientific career | |
Fields | Glaxo |
Doctoral advisor | Arnold Beckett |
Sir David Jack Glaxo from 1978 until 1987.
Early life and education
Jack was born the sixth and youngest child of a coal miner, in
Royal Technical College, Glasgow. He won a number of undergraduate prizes and graduated with first class honours.[4]
Career
He turned down an offer to study for a doctorate and instead worked as an assistant lecturer at the University of Glasgow.[1][4]
In 1951 he joined the pharmaceutical company
Allen and Hanburys, a subsidiary of Glaxo, and served as Glaxo's research and development director from 1978 until his official retirement in 1987.[2]
Jack was known for heading a group which developed the following drugs:
- Beclometasone in 1962
- Salbutamol or Albuterol in 1966,
- Ranitidine in 1977,
- Sumatriptan in 1984,
- Salmeterol or serevent in 1985,
- Ondansetron in 1987,
- and Fluticasone propionate in 1993.
Honours
Jack was knighted for services to the pharmaceutical industry in 1993.[4]
In 1987, he was awarded an Honorary Degree (Doctor of Science) by the University of Bath.[5]
References
- ^ .
- ^ a b "Sir David Jack". The Daily Telegraph. 17 November 2011. Retrieved 25 November 2011.
- ^ "Sir David Jack". The Herald. 19 November 2011.
- ^ a b c d e "Obituary, Sir David Jack". The Times. Retrieved 18 November 2011.
- ^ "Honorary Graduates 1989 to present". bath.ac.uk. University of Bath. Archived from the original on 19 December 2015. Retrieved 18 February 2012.
External links
- Last Word 25/11/2011 BBC Radio 4.
- Interviews with Sir David Jack CBE FRS FRSE. Oxford Brookes University Library Medical Sciences Video Archive
- David Jack on the History of Modern Biomedicine Research Group website